This study was supported by National Key R&D Program of China (2023YFC2509100), Science and Technology Commission of Shanghai Municipality (23Y31900400), National Natural Science Foundation of China (82370984 & 82370980), Natural Science Foundation of Shanghai (22ZR1437600), Shanghai's Top Priority Research Center (2022ZZ01017), and Dominant disease biological sample project of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (YBKA202201)
Common Side Effects: Patients using Mounjaro (tirzepatide) may experience similar side effects to other GLP-1 medications, such as nausea, vomiting, and digestive discomfort
The only significant relationship that was observed between behavioral symptom assessments and metabolite levels was the positive correlation between GABA levels, both in SM1 (correlation coefficient=0.52, p 3.0.CO;2-J 80. Miyajima, M., Omiya, H., Yamashita, K., Yambe, K., Matsui, M., & Denda, K
Originally developed for diabetes treatment, GLP-1 drugs curb appetite and change eating preferences